Please wait...


Detection of SARS-CoV-2 RNA For the Diagnosis of COVID-19

The MatMaCorp COVID-19 test system uses three innovative technologies to isolate, amplify, and detect SARS-CoV-2 from nasopharyngeal swab samples.

Key Features
  • Easy RNA isolation in just 15 minutes using the MatMaCorp Direct RNA isolation method
  • Lyophilized reagents in the MatMaCorp COVID-19 Test Kit allows ambient shipping and storage – no refrigeration
  • Fluorescent detection, automatic calling, and reporting of results on the MatMaCorp Solas 8 device
Test Details
  • Sensitive to as little as 40 viral genomes per reaction
  • Specifically detects SARS-CoV-2; no cross-reaction with other viral and bacterial pathogens
  • Compatible with all standard transport media.
Platform Details
  • No other reagents or kits supplied by the user – everything needed for testing is included
  • Instructions and data displayed on screen and with LAN, WiFi, or access point connectivity
  • Full software package, including sample database, is included
Additional Statements About COVID-19 Tests
  • This test has not been FDA cleared or approved
  • This test has been submitted to the FDA under an EUA for use by authorized laboratories

MatMaCorp's COVID-19 Test Kit requires specimens collected from the nose which must be collected by a healthcare provider. The preferred sample types are nasopharyngeal (NP) swabs.

No. MatMaCorp's COVID-19 Test Kit requires specimens to be collected by a healthcare provider.

  • Limit of Detection (LoD) – The MatMaCorp COVID-19 test was determined to have a LoD of 800 genome equivalents per mL (40 genome equivalents per 50 ul reaction)
  • Clinical Evaluation – The MatMaCorp COVID-19 test correctly detected 29 out of 30 clinical positive samples (96.7% concordance) and 30 out of 30 clinical negative samples (100% concordance), compared to the comparator method
  • Inclusivity/reactivity – The MatMaCorp COVID-19 test is expected to detect at least 99.8% of sequences from known SARS-CoV-2 isolates, based on in silico analysis for inclusivity
  • Specificity/cross-reactivity – The MatMaCorp COVID-19 test is not expected to cross-react with any normal or pathogenic respiratory flora likely to be encountered in a clinical specimen, based on in silico analysis for specificity

Demo Video Order Now

Item name COVID-19 Test Kit
Catalog Number ST-CV19-L
Availability Please call to order
Application For the in vitro qualitative detection of RNA from SARS-CoV-2 in nasopharyngeal swabs
Use with Solas 8® Device, Cat # SOL8